Literature DB >> 11157911

Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study.

J Oteo1, J I Alós, J L Gómez-Garcés.   

Abstract

Resistance to first-line antimicrobial agents in Streptococcus pneumoniae is increasing worldwide and the new fluoroquinolones may provide a good alternative. The antimicrobial susceptibility to levofloxacin and 13 other antibiotics of 300 isolates of S. pneumoniae, isolated in the Madrid community in 1999 and 2000, was determined. A total of 65.6% of isolates were penicillin intermediate or resistant strains. A high percentage of resistance to macrolides, clindamycin, tetracycline and chloramphenicol was also observed, mainly in penicillin-resistant strains. All but one strain was susceptible to levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157911     DOI: 10.1093/jac/47.2.215

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).

Authors:  Ronald N Jones; Alan H Mutnick; David J Varnam
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.

Authors:  Daniel F Sahm; Clyde Thornsberry; David C Mayfield; Mark E Jones; James A Karlowsky
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.

Authors:  Jesús Oteo; Edurne Lázaro; Francisco J de Abajo; Fernando Baquero; José Campos
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

Authors:  Marc Miravitlles; Rafael Zalacain; Cristina Murio; Montserrat Ferrer; José L Alvarez-Sala; Juan F Masa; Héctor Verea; Fernando Ros; Rafael Vidal
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 5.  Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.

Authors:  Wael E Shams; Martin E Evans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones.

Authors:  J Mensa; A Trilla
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.